https://www.selleckchem.com/pr....oducts/mivebresib-ab
Patients with diabetic mellitus (DM) and chronic kidney disease (CKD) are at an increased risk of urinary tract infection (UTI) due to their altered immunologicalintegrity. These patients are similarly prone to developing frailty, a state of cumulative health deficits involving multiple domains and leading to adverse outcomes. Whether frailty predisposes affected individuals to UTI among patients with DM and CKD remains unclear. A population-based cohort of patients with DM and CKD (n = 79,887) were assembled from the Longit
Like
Comment
Share
